Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

339 results about "Serum protein" patented technology

Culture medium for immune cells as well as preparation method and application of culture medium

The invention provides a culture medium for immune cells as well as a preparation method and application thereof. On the basis of a serum-free culture medium, a specific additive is added into the culture medium and is used as a nutrient substance for growth of immune cells, so that the concentrations of various components in the final culture medium are fixed, the culture efficiency of the immune cells is improved, the cell activity is increased, and the repeatability of subsequent experiments is ensured. Meanwhile, due to the use of a specific additive, animal serum protein added into a conventional culture medium is avoided, so that the risk of infection of exogenous viruses and pathogenic factors is avoided, the immune cells obtained by culture have no sensitization, and the condition that a receptor is allergic to exogenous serum is avoided. In addition, the cost of the immune cell culture medium is reduced, and the preparation process of the culture medium is simplified. Compared with the prior art, the additive provided by the invention can be preserved for a long time in a low-temperature environment, the activity is kept unchanged, and the additive can be taken and used when a culture medium is prepared, so that the preservation cost of immune cells is effectively reduced.
Owner:NANJING AIPU BIOMEDICAL TECH CO LTD +1

Biomarker related to diabetic neuralgia and application thereof

The invention discloses a biomarker related to diabetic neuralgia and application of the biomarker. The biomarker is IGFBPs or CD324. According to the application, a DNP (Diabetic Neuralgia) rat model is constructed, the DIA and DDA combined technology is adopted, DNP model rats are subjected to serum proteome detection, and through analysis, screening and verification, compared with normal group rats, the expression level of IGFBPs or CD324 in serum of the DNP model rats has significant difference; according to the method, IGFBPs or CD324 is taken as a biomarker, a working characteristic curve (ROC) of a subject is drawn at the same time, and IGFBPs or CD324 is evaluated according to area under the curve (AUC) to have excellent diagnostic efficiency when applied to diabetic neuralgia as the biomarker, so that a new biomarker can be provided for auxiliary diagnosis of diabetic neuralgia, and clinical diagnosis of diabetic neuralgia is more convenient and accurate.
Owner:UNIV OF SCI & TECH OF CHINA +1

Application of N-acetyl serotonin in prevention and treatment of diabetes

ActiveCN119345192ASignificant improvementImproves glucose tolerance levelOrganic active ingredientsMetabolism disorderSerotoninBeta-cell Function
The invention relates to the technical field of biological medicines, in particular to application of N-acetyl serotonin in prevention and treatment of diabetes mellitus, and tests show that NAS has an obvious improvement effect on symptoms of weight loss, water intake increase and diet increase of T2DM mice; the NAS is used for improving the fasting blood glucose and the glucose tolerance level of the T2DM mouse; the NAS reduces the glycated serum protein and insulin resistance level of the T2DM mouse; the pancreatic beta cell function and insulin sensitivity of the T2DM mouse are improved. Therefore, the medicine N-acetyl serotonin has a good clinical application prospect in treating the type 2 diabetes mellitus and has important significance in developing a novel medicine composition for treating the type 2 diabetes mellitus.
Owner:GUANGXI MEDICAL UNIVERSITY

Construction method and system of chronic hepatitis B liver inflammation grading prediction model and application

The invention provides a construction method and system of a chronic hepatitis B liver tissue inflammation grading prediction model and application. The construction method of the chronic hepatitis B liver tissue inflammation grading prediction model comprises the following steps: S1, screening out a plurality of patients which are diagnosed as chronic hepatitis B through liver tissue biopsy pathology and have clear liver tissue inflammation grading according to inclusion and exclusion standards, and collecting clinical data and serum samples of the patients; s2, performing serum protein N-carbohydrate chain fingerprint spectrum difference analysis on the serum samples of the patients with different ALT levels by adopting an N-carbohydrate fingerprint spectrum technology; s3, on the basis of conventional biochemical indexes and / or N-sugar markers, constructing liver tissue inflammation grading evaluation models under different ALT levels by adopting a binary logistic regression analysis method; and S4, respectively evaluating and selecting the model with the optimal efficiency as a chronic hepatitis B liver tissue inflammation grading prediction model. The chronic hepatitis B liver tissue inflammation grading method can be used for quickly, accurately and noninvasively grading the chronic hepatitis B liver tissue inflammation.
Owner:YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE

Protein joint detection-based viral ARDS prognosis evaluation system and method

The invention discloses a viral ARDS prognosis evaluation system based on protein joint detection, and the system comprises a sample processing module which is used for carrying out serum standardization pretreatment; the protein detection module is used for performing iBAQ quantification of IL6ST / FOXO3 / TLR7 based on DIA mass spectrometry, defining a targeted therapy threshold value and realizing targeted quantification of the core protein; and the intelligent analysis module is used for realizing cross-age risk layering based on a multivariable logic regression model. B cell function states are reflected by combining serum IL6ST / FOXO3 / TLR7 protein expression levels, a multivariable logistic regression model is constructed, and unified risk stratification of patients of all ages from children to the elderly is achieved; by locking an IL6ST / FOXO3 / TLR7 pathway, a targeted therapy threshold is defined to directly guide targeted therapy, and immune intervention is facilitated.
Owner:中国人民解放军总医院第八医学中心

Conjugate of indocyanine green and multi-arm polyethylene glycol or pharmaceutically acceptable salt thereof as well as preparation method and application of conjugate

The invention relates to the technical field of tumor fluorescence contrast agents, and particularly provides a conjugate of indocyanine green and multi-arm polyethylene glycol or pharmaceutically acceptable salt of the conjugate and a preparation method and application of the conjugate, the conjugate has the structural formula shown in the formula (I), the binding capacity of the conjugate and serum protein is remarkably reduced, and the conjugate can be applied to tumor fluorescence contrast agents. According to the present invention, the tumor targeting property is significantly improved, and the tumor is accumulated and detained in the tumor tissue, such that the targeted treatment or the high-resolution imaging is achieved so as to achieve the accurate tumor positioning and diagnosis, the high application value is provided, and the new method is developed for the tumor imaging and the treatment.
Owner:NANJING YUNYING BIOTECHNOLOGY CO LTD

Enteromorpha oligosaccharide as well as preparation method and application thereof

The invention discloses enteromorpha oligosaccharide as well as a preparation method and application thereof. The enteromorpha oligosaccharide is prepared by degrading enteromorpha polysaccharide, the polymerization degree is 2-10, the enteromorpha oligosaccharide contains rhamnose, glucose, glucuronic acid and xylose, and the preparation method is simple. By constructing a type 2 diabetes mellitus mouse model, it is verified for the first time that the enteromorpha oligosaccharide can significantly reduce the fasting blood glucose level of the type 2 diabetes mellitus mouse, reduce the insulin content in serum and the glycated serum protein level, improve the blood fat metabolism capability of the type 2 diabetes mellitus mouse, and improve the activity of the enteromorpha oligosaccharide in the type 2 diabetes mellitus mouse. According to the enteromorpha oligosaccharide, the liver glycogen synthesis capacity in the mouse liver is improved, the abnormal liver function of the mouse with the type 2 diabetes mellitus is improved, the safety of the enteromorpha oligosaccharide is high, and the enteromorpha oligosaccharide has a good prospect in the aspect of developing food or drugs with the function of controlling the type 2 diabetes mellitus.
Owner:FIRST INSTITUTE OF OCEANOGRAPHY MNR

Intelligent breast lump diagnosis system based on combination of ultrasonic-molybdenum target multi-mode image and serum P16 protein detection

InactiveCN120585359AImage enhancementImage analysisMammary gland massCalcification cluster
The invention relates to the technical field of ultrasonic and molybdenum target detection, in particular to an intelligent breast lump diagnosis system based on ultrasonic-molybdenum target multi-modal image and serum P16 protein detection, and the intelligent breast lump diagnosis system is characterized in that an ultrasonic image, a molybdenum target image and multi-modal data of serum P16 protein detection are fused; and optimal integration of cross-modal features is realized through a dynamic weight strategy. The ultrasonic image provides morphological and hemodynamic information of the lumps; the molybdenum target image reveals the characteristics of calcification density, calcification cluster heterogeneity, structure distortion depth and the like; serum P16 protein detection prompts malignant risks from the molecular level, and especially has important value in early recognition of triple negative breast cancer. A feature association graph is constructed through a graph neural network (GNN), the weight is dynamically adjusted in combination with a Bayesian probability integration formula, and optimal fusion of different modal features is ensured. The limitation of a single mode is made up, and the sensitivity and the specificity of diagnosis are also remarkably improved.
Owner:TANGSHAN PEOPLES HOSPITAL

Novel anti-fouling material OPA-CsPbBr3 as well as preparation method and sensing application thereof

ActiveCN119060224AImprove hydrophilicityHas glucose oxidase-like activityMaterial analysis by electric/magnetic meansElectrochemical biosensorGlucose oxidase activity
The invention belongs to the technical field of electrochemical detection, and relates to a novel anti-fouling material OPA-CsPbBr3 as well as a preparation method and sensing application thereof. The antifouling material OPA-CsPbBr3 is formed by doping an OPA polymer into CsPbBr3, on one hand, OPA has good hydrophilicity and is nearly neutral, so that the antifouling material shows excellent antifouling performance; on the other hand, the water stability of CsPbBr3 can be further improved, so that the CsPbBr3 shows excellent glucose oxidase-like activity. The invention further provides an anti-fouling electrochemical biosensor which takes OPA-CsPbBr3 as an anti-fouling material and peptide nucleic acid (PNAs) as a sensing probe, and the anti-fouling electrochemical biosensor can efficiently resist non-specific adsorption of biomolecules such as protein in a complex biological sample (such as blood and serum). In addition, nano enzyme cascade catalysis and a CRISPR / Cas13a system are integrated, so that the detection sensitivity of the anti-fouling electrochemical biosensor is further enhanced, and sensitive detection of miRNA-let-7a in a complex biological sample is realized.
Owner:NINGXIA UNIVERSITY

Synergistic dual-mode anticoagulation and anti-inflammatory bionic central venous catheter coating and preparation method thereof

The invention discloses a synergistic dual-mode anticoagulation and anti-inflammatory central venous catheter BC-BCD double-layer bionic hydrogel coating and a preparation method thereof. BSA / CBAA hydrogel formed by copolymerizing bovine serum albumin and carboxyl betaine acrylamide is used as an outer coating of the catheter, dopamine containing catechol groups is introduced as a main chain network, and BSA / CBAA / DA hydrogel is obtained and used as an inner coating of the catheter. The two layers are combined through a two-step impregnation method to obtain the BC-BCD double-layer bionic coating, thrombus can be defended on a catheter interface in an active mode and a passive mode, oxidation factors in a body can be removed, oxidative stress and bacterial infection can be reduced, and the BC-BCD double-layer bionic coating can be tightly attached to a base material. Experimental results show that the prepared bionic hydrogel coating has excellent anticoagulation and anti-inflammatory performance and long-term stable adhesion performance, the main defects of a traditional central venous catheter are remarkably overcome, and the bionic hydrogel coating has a positive effect on clinical prevention of thrombus and infection.
Owner:FUZHOU UNIV

Chemiluminescence kit for detecting pepsinogen II and preparation method thereof

The invention relates to a chemiluminescence kit for detecting pepsinogen II. The kit comprises an enzyme marker, a luminescent substrate solution and an anti-interference buffer system, the anti-interference buffer system comprises a nonionic surfactant, animal-derived IgG (immunoglobulin G), an antioxidant and catalase; the chemiluminescence kit also comprises a PG II calibration product and a PG II quality control product. The core active component of the enzyme marker is beta-galactosidase. The enzyme marker further comprises an anti-PG II monoclonal antibody marked by beta-galactosidase, bovine serum albumin, trehalose, cane sugar, MgCl2. 6H2O, sodium chloride, Proclin300 and a phosphate buffer solution. According to the kit, a brand-new anti-interference buffer system is introduced on the basis of a spatial proximity chemiluminescence analysis method, so that the resistance to clinically common interferents (such as hemolysis, lipemia, jaundice and heterotropism antibodies) is remarkably improved, and the detection result is more accurate and reliable.
Owner:山东九嘉生物科技有限公司

Metabolic disease onset risk prediction model and construction method thereof

The invention discloses a metabolic disease onset risk prediction model and a construction method thereof. Based on serum proteome data of a large-scale longitudinal population queue, a health aging score including 22 serum proteins is developed, and the onset risk of metabolic diseases of middle-aged and elderly individuals within 9 years can be measured. The health aging score is helpful for preventing and treating aging-related metabolic diseases and promoting health aging.
Owner:WESTLAKE UNIV

Microbial dust suppressant reinforced by utilizing extracellular polymeric substance as well as preparation method and application of microbial dust suppressant

The invention provides a microbial dust suppressant reinforced by an extracellular polymeric substance as well as a preparation method and application of the microbial dust suppressant, and belongs to the technical field of dust prevention and dust suppression of coal mines. The preparation method comprises the following steps: adding at least one of a chitosan solution and a bovine serum albumin solution into a culture medium, and adding a bacterial solution; mixing calcium chloride and urea to form a cementing liquid; and mixing the cementing liquid with the cultured bacterial liquid added with at least one of the CTS solution and the BSA solution to obtain the extracellular polymeric substance reinforced microbial dust suppressant. According to the invention, consolidation layers of coal dust can be increased, nucleation sites are increased, calcium carbonate precipitation is promoted, secondary pollution is avoided, the effect is good, and the cost is low. Compared with a common microorganism dust suppressant, the environment-friendly dust suppressant has the characteristics of being environment-friendly and fast in dust suppression effect.
Owner:SHANDONG UNIV OF SCI & TECH

Cerebral nerve cell targeted gene protein co-loaded nano delivery system and preparation method thereof

The invention discloses a brain nerve cell targeted gene protein co-loaded nano delivery system and a preparation method thereof, phenylboronic acid modified polyethyleneimine is synthesized through substitution reaction, then the polyethyleneimine is compounded with DNA through electrostatic interaction to form a PEI-PBA / DNA nano compound, bovine serum albumin is loaded through nitrogen-boron complexation, and the brain nerve cell targeted gene protein co-loaded nano delivery system is obtained. The preparation method comprises the following steps: preparing a gene-protein co-loaded nano delivery system PPDB, further endowing the nano delivery system with a function of crossing a blood brain barrier, and introducing glycerophosphorylcholine through the formation of a borate bond, so as to prepare the cerebral nerve cell targeted gene-protein co-loaded nano system PPDBG. The preparation method disclosed by the invention is simple, realizes simultaneous loading of genes and proteins with completely different physical structures, and has very important research significance on brain-related diseases such as epilepsy and the like. Meanwhile, the introduction of the boric acid ester bond endows the nano delivery system with the on-demand plug-and-play characteristic, so that the spectral applicability of the nano delivery system is realized.
Owner:TIANJIN UNIV

Biomarker combination related to hypoxia-induced neuroinflammation and application thereof

The invention discloses a biomarker combination related to hypoxia-induced neuroinflammation and application of the biomarker combination, and belongs to the technical field of biomarker detection. The marker combination disclosed by the invention consists of serum S100 beta protein, neuron-specific enolase, interleukin-6, high-mobility group protein B1 and neurofilament light-chain protein. The marker combination can be used for stratification of nervous system injury risk of severe hypoxia patients and acquisition of prognosis evaluation data. According to the detection method disclosed by the invention, synchronous quantitative detection of five markers is realized by adopting a multiple immunofluorescent microsphere technology, and a marker combination scoring algorithm is established to comprehensively evaluate the severity of the hypoxia-related neuroinflammation.
Owner:THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIV

Serum protein removal method and propofol rapid detection method

The invention discloses a serum protein removal method and a rapid propofol detection method, and relates to the technical field of propofol detection.The serum protein removal method comprises the steps that a serum sample and 50% trichloroacetic acid are ultrasonically mixed to be uniform and centrifuged, and supernate without protein is obtained; the rapid propofol detection method comprises the following steps: S1, adopting the serum protein removal method; s2, ultrasonically and uniformly mixing the supernate with an organic solvent, and centrifuging to obtain an organic phase containing propofol; and S3, mixing the organic phase with a molecular probe and an alkali solution for reaction and color development, and measuring an absorbance value. According to the scheme, the concentration of the propofol in the serum can be accurately and rapidly detected.
Owner:SICHUAN RUNYU KANGXI MEDICAL TECH CO LTD

Biotinylated tyrosine phosphatase antigen preserving fluid as well as preparation method and application thereof

The invention relates to the technical field of reagent preservation, in particular to biotinylated tyrosine phosphatase antigen preservation liquid as well as a preparation method and application thereof. The pH value of the biotinylated tyrosine phosphatase antigen preserving fluid is 7.0-7.5, and the biotinylated tyrosine phosphatase antigen preserving fluid is prepared from the following raw material components: a buffering agent, soluble metal salt, an organic dispersing agent, poly (ethylene glycol)-block-poly (propylene glycol)-block-poly (ethylene glycol) 8400, a metal ion complexing agent, bovine serum albumin, a protein protective agent and a preservative. By optimizing the components of the biotinylated tyrosine phosphatase antigen preserving fluid, when the prepared antigen preserving fluid is used for preserving a biotin-labeled tyrosine phosphatase antigen, the storage life is greatly prolonged under the condition of 2-8 DEG C. The biotinylated tyrosine phosphatase antigen preserving fluid prepared by the method is convenient to use, stable to store, economical and practical, and simple to prepare.
Owner:AUTOBIO DIAGNOSTICS CO LTD

Bovine serum albumin purification device

The utility model relates to a bovine serum albumin purification device, and aims to improve the dropping precision of a salt solution in a protein purification process through automatic design and accurate control. The device comprises a pump box, a conveying wheel set, a liquid conveying rubber pipe, a driving motor and a liquid storage tank. The driving motor drives the conveying wheel set to rotate, and the abutting roller in the conveying wheel set revolves around the main shaft sleeve to extrude the liquid feeding rubber pipe, so that the salt solution is pushed to move along the pipeline, and accurate dripping of the liquid is realized. A groove gland is arranged on one side of the pump box and used for pressing the liquid conveying rubber pipe when the conveying wheel set is not started, and liquid leakage is prevented. The arrangement of the adjusting disc allows the abutting roller to be adjusted in the radial direction so as to adapt to liquid feeding rubber pipes of different specifications, and therefore the output amount of the salt solution is accurately controlled. The device is simple in structure and convenient to operate, can effectively improve the purification efficiency and quality of bovine serum albumin, and is suitable for various experiments and production environments.
Owner:JIANGSU MRC BIOLOGICAL TECH CO LTD

Novel serum protein marker combination for evaluating depth of anesthesia and application of novel serum protein marker combination

PendingCN121899423ADisease diagnosisBiological testingNeurophysiological MonitoringReceptor subunit
The invention belongs to the technical field of in-vitro diagnosis and anesthesia monitoring. The invention discloses a serum protein marker combination for evaluating anesthesia depth and application of the serum protein marker combination. The composition is composed of orexin, S100 calcium binding protein B, C reactive protein and gamma-aminobutyric acid A type receptor alpha1 subunit, and can synergistically reflect the anesthesia sedation state from multiple dimensions. The invention also provides a detection kit containing the marker and application of the detection kit in evaluation of anesthesia depth. The combination has the advantages of being high in accuracy, objective, stable and easy to detect, can serve as an effective supplementary tool of an existing nerve electrophysiology monitoring technology, and provides a new reference means for intraoperative sedation depth monitoring and precise anesthesia management.
Owner:JIANGSU TAIZHOU PEOPLES HOSPITAL

A method for preparing low-concentration bovine serum albumin synergized by pulsed electric field

The present invention discloses a method for preparing low-concentration bovine serum albumin with pulse electric field synergistic glycosylation. In the case of 0.8wt%-3wt% low-concentration bovine serum albumin, the temperature is raised to 85-95°C to coordinate pulse electric field treatment, which greatly improves the reaction efficiency of the glycosylation reaction, achieves a higher grafting degree, improves the emulsification and emulsifying properties of BSA, and reduces unnecessary color browning, so that it has a broader application prospect.
Owner:SOUTH CHINA UNIV OF TECH

A nanogene composition for treating brain glioma and a preparation method thereof

The application belongs to the technical field of biomedical engineering, and specifically discloses a nano gene composition for treating brain glioma and a preparation method thereof, which is synthesized from bovine serum albumin loaded manganese dioxide particles, PLGA, DSPE-PEG3000 and DSPE-PEG-Angiopep2 as raw materials; the average particle size of the nano gene composition is 122.18±31.3 nm. The application also discloses a preparation method of the nano gene composition. The nano gene composition provided by the application encapsulates miRNA-138 in PLGA to avoid the degradation of miRNA-138 by RNA enzymes in the body, and simultaneously utilizes the targeting property of Angiopep2 to target the delivery of the nano gene composition to tumor tissues, to deliver microRNA into the brain while reducing tumor hypoxia and increasing the sensitivity of cells to X-ray irradiation, so as to realize multidirectional comprehensive treatment of glioblastoma.
Owner:SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV

Polypeptide targeting BRAF dimer and application of polypeptide in tumor resistance

The invention relates to the technical field of biological medicines, and provides a polypeptide targeting a BRAF dimer and an application of the polypeptide in tumor resistance, the polypeptide takes a straight-chain peptide TRHVNILLFM-OH as a peptide chain template, the straight-chain peptide is constructed through specific amino acid replacement, the C terminal is gradually truncated and cyclized to construct a cyclic peptide, and a specific sequence is coupled to develop a composite peptide strategy for modification, so that the polypeptide targeting the BRAF dimer is obtained. The cyclic peptide CBF-2, the cyclic peptide CBF-2-2 and the cyclic peptide SCBF-2-2 are obtained. Experiments prove that the polypeptide can effectively inhibit proliferation and invasion of tumor cells; the serum protein has high stability and excellent cell penetrating capability, and can penetrate through a cell membrane to enter cytoplasm, so that target protein in cells can be better targeted to exert biological functions of the target protein. Therefore, the multi-functional composite peptide can be developed through a polypeptide modification strategy, the membrane permeability and the stability of the multi-functional composite peptide are improved, the binding force of the multi-functional composite peptide and the BRAF protein is further improved, and the effects of inhibiting proliferation of tumor cells and resisting invasion are achieved at the same time.
Owner:THE NAVAL MEDICAL UNIV OF PLA

A polyacid tannic acid modified ultrafiltration membrane, a preparation method and application thereof

The application discloses a preparation method and application of a polyacid tannic acid modified ultrafiltration membrane, and the preparation method comprises the following steps: preparing a casting solution containing a high molecular film forming material and a solvent; adding a polyoxometalate into the casting solution, uniformly mixing, and obtaining a polyacid modified casting solution; scraping and coating the polyacid modified casting solution to form a liquid membrane, pre-evaporating, immersing into a coagulation bath containing tannic acid to perform phase inversion and film forming, and obtaining the polyacid tannic acid modified ultrafiltration membrane. Through the synergistic effect of the polyacid blending regulation of the membrane pore structure and the in-situ coordination modification of the tannic acid phase separation, the simultaneous improvement of the permeation flux and the retention rate is realized, the pure water flux of the obtained ultrafiltration membrane reaches 221.37 LMH, the bovine serum albumin retention rate reaches 96.17%, and the preparation process is simple, efficient, and has a good large-scale application prospect.
Owner:NANTONG UNIV

A low-temperature freezing protection solution for koi herpes virus and its preparation method and application

The present invention provides a cryopreservation solution for Koi herpesvirus, as well as its preparation method and application, relating to the field of virus preservation technology. The solution comprises 2-8 w / v% hydroxyethyl starch, 3-5 w / v% sucrose, and 1-3 w / v% bovine serum albumin. The Koi herpesvirus has an activity of ≥90% after resuscitation, can withstand five freeze-thaw cycles, can be stably frozen at -20°C, and has a shelf life of up to two years. This solution solves the technical problems in the prior art, such as the need to store cryopreservation solutions at ultra-low temperatures, the risk of osmotic pressure imbalance and viral envelope rupture, and low activity after cryopreservation and resuscitation.
Owner:NINGBO SANSHENG BIOLOGICAL TECH CO LTD

Micro-amount serum tumor whole-process screening detection method based on nucleic acid aptamer group alignment

The application discloses a micro serum tumor whole-process screening detection method based on nucleic acid aptamer group comparison, and comprises the following steps: firstly, 24+1 tumor and non-tumor specific nucleic acid aptamer groups are screened by using bidirectional thermal cycle subtraction SELEX technology; data of the specific nucleic acid aptamer groups are used to create a standard database; the specific nucleic acid aptamer groups are mixed in equal proportions to develop 24+1 tumor and non-tumor specific nucleic acid aptamer detection reagents; in the detection process, the detected sample forms a magnetic bead-sample serum protein complex, and then is combined with the aptamer detection reagent; a magnetic bead-serum protein-sample specific nucleic acid aptamer complex is formed, and sample specific nucleic acid aptamer is separated and obtained; and the sample specific nucleic acid aptamer is compared and analyzed with the standard database, so that the sample detection technology method is realized. The method has the advantages of small sample amount, automatic process completion, high throughput, wide tumor screening range and the like, and meets the requirements of high-throughput tumor screening.
Owner:LANZHOU XINLIN BIOTECHNOLOGY DEV CO LTD

Methods and compositions for treating inflammatory and autoimmune disorders with ECM-affinity peptides linked to anti-inflammatory agents

The present disclosure relates to collagen binding modification engineering of anti-inflammatory agents using collagen binding peptides (CBP) and vWF A3 to achieve targeted therapy of inflammatory diseases. Accordingly, embodiments of the present disclosure relate to compositions comprising an anti-inflammatory agent operably linked to an extracellular matrix (ECM) affinity peptide. Also disclosed are cytokines and anti-inflammatory agents, such as CD200, linked to serum proteins and / or ECM affinity peptides. Other aspects of the present disclosure relate to methods for treating an autoimmune or inflammatory disorder in a subject comprising administering to the subject a composition of the present disclosure.
Owner:UNIVERSITY OF CHICAGO

Metal carbonyl Mn complex taking 2-picolinic acid derivative as ligand as well as preparation method and application of metal carbonyl Mn complex

The invention belongs to the technical field of synthesis and application of complexes, and provides a metal carbonyl Mn complex taking a 2-picolinic acid derivative as a ligand as well as a preparation method and application of the metal carbonyl Mn complex. The chemical formula of the complex is [Mn (CO) 3 (L) Br], L is 2-picolinic acid, 5-Cl-2-picolinic acid, 5-Br-2-pyridylaldehyde or 6-Br-2-picolinic acid methyl ester, and the complex with four different substituent groups has high water solubility and has an obvious effect on improving the water solubility of CORM. The four complexes can realize CO controllable release under different illumination wavelengths, and can be applied to preparation of donors capable of realizing CO controllable release in visible light or near-infrared light. The compound can be combined with human serum protein to prepare a serum protein complex, and can be applied to metabolism regulation and cell targeting carrying of the complex. The growth of human cervical cancer HeLa cells is obviously inhibited, and the compound can be applied to screening and preparation of lead compounds of anti-tumor drugs.
Owner:SHANXI UNIV

UPLC-MS (Ultra Performance Liquid Chromatography-Mass Spectrometry)-based screening method of medicine for inhibiting activity of advanced glycosylation end product

The invention discloses a UPLC-MS (Ultra Performance Liquid Chromatography-Mass Spectrometry)-based screening method of a medicine for inhibiting the activity of an advanced glycosylation end product. According to the method, bovine serum albumin and ribose are used for synthesizing AGEs in vitro to determine whether a selected medicine has the AGEs inhibition capability or not, and the medicine with the inhibition capability is selected; then simulating in-vivo diabetes by using a high-glucose cell model, and identifying the drug with the highest inhibition capability by cell experiments; and finally, establishing a diabetes animal model to detect screening in cell experiments. The method provided by the invention is simple and efficient, and can be used for rapidly screening required drugs for treating AGEs related diseases.
Owner:NANJING UNIV OF SCI & TECH

Use of ubqln1 protein in cirrhosis diagnostic products, kits and in vitro detection methods

The application belongs to the field of biotechnology, and particularly relates to application of UBQLN1 protein in a cirrhosis diagnosis product, a kit and an in vitro detection method. The application comprises: using serum UBQLN1 protein as a marker, and applying the marker in preparation of a product for diagnosing or assisting in diagnosing cirrhosis; or applying the marker in preparation of a product for distinguishing cirrhosis from healthy individuals; or applying the marker in preparation of a product for evaluating progression of cirrhosis or a degree of liver fibrosis; and applying the marker in screening or evaluating a drug for preventing and / or treating cirrhosis.
Owner:CHANGZHOU WUJIN PEOPLES HOSPITAL (CHANGZHOU EIGHTH PEOPLES HOSPITAL) +1